From : Tamar Gabunia </O=EXCHORGANIZATION/OU=EXCHANGE ADMINISTRATIVE GROUP (FYDIBOHF23SPDLT)/CN=RECIPIENTS/CN=E6CA04F38EC94D0CADAB9CBDF90FCDDE-TAMAR G>
To : Sebastian-A Molineus <smolineus@worldbank.org>
Subject : RE: AstraZeneca updated results released
Cc : Nino V. Moroshkina <nmoroshkina@worldbank.org>; Volkan Cetinkaya <vcetinkaya@worldbank.org>; Ahmet Levent Yener <alyener@worldbank.org>
Received On : 25.03.2021 13:45
Attachments :

Dear Sebastian

Thanks a million for sharing!

Best

Tamar

 

From: Sebastian-A Molineus [mailto:smolineus@worldbank.org]
Sent: 25 March, 2021 15:59
To: Tamar Gabunia
Cc: Nino V. Moroshkina ; Volkan Cetinkaya ; Ahmet Levent Yener
Subject: FW: AstraZeneca updated results released

 

Hi Tamar – am sure you’ve seen, but sharing for info. just in case. 

 

 

Thank you and kind regards,

Sebastian

 

 

Sebastian Molineus
Regional Director for the South Caucasus
Europe and Central Asia
+995 (32) 291 6238
M +995 (577) 78 7821
M +1 (202) 492-3914
E  smolineus@worldbank.org
W www.worldbank.org/en/region/eca

 @smolineus

www.linkedin.com/in/molineus/

 

 

 

 

 

 

 

From: Fadia M. Saadah <fsaadah@worldbank.org>
Sent: Thursday, March 25, 2021 3:18 PM
To: ECA RLT Full <eca_rlt_full_internal_use_only@worldbank.org>
Subject: FW: AstraZeneca updated results released

 

Some good new on AZ

 

From: David Wilson <dwilson@worldbank.org>
Sent: Thursday, March 25, 2021 3:10 AM
To: David Wilson <dwilson@worldbank.org>
Subject: AstraZeneca updated results released

 

AZ updated efficacy with new cases 76% but they are still assessing some unclear cases. 85% among over 65. 8 severe cases all in control group.

 

https://www.astrazeneca.com/media-centre/press-releases/2021/azd1222-us-phase-iii-primary-analysis-confirms-safety-and-efficacy.html